Original Research
Published on 02 Aug 2017
Kininase 1 As a Preclinical Therapeutic Target for Kinin B1 Receptor in Insulin Resistance
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00509
- 4,347 views
- 14 citations
